Elliott Robinson - 17 Feb 2026 Form 4 Insider Report for Hinge Health, Inc. (HNGE)

Role: Director, 10%+ Owner
Signature: /s/ Augie Wilkinson, Attorney-in-Fact
Issuer symbol: HNGE
Transactions as of: 17 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 19 Feb 2026, 19:12:52 UTC
Previous filing: 17 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Robinson Elliott	Director, 10%+ Owner	C/O BESSEMER VENTURE PARTNERS, 1865 PALMER AVENUE, SUITE 104, LARCHMONT	/s/ Augie Wilkinson, Attorney-in-Fact	19 Feb 2026	0002058536

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HNGE	Class A Common Stock	Sale	$0	0		$0.000000^*	0	17 Feb 2026	See footnote	F1, F3
transaction	HNGE	Class A Common Stock	Sale	$0	0		$0.000000^*	0	18 Feb 2026	See footnote	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 17, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 46,276 and 43,440 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $39.929. These shares were sold in multiple transactions at prices ranging from $39.50 to $40.31. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2	On February 18, 2026, BVP X and BVP X Inst sold 48,353 and 45,390 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $40.358. These shares were sold in multiple transactions at prices ranging from $39.535 to $40.855. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3	The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities.